Drug delivery of memantine with carbon dots for Alzheimer’s disease: blood–brain barrier penetration and inhibition of tau aggregation
- 1 March 2022
- journal article
- research article
- Published by Elsevier BV in Journal of Colloid and Interface Science
- Vol. 617, 20-31
- https://doi.org/10.1016/j.jcis.2022.02.124
Abstract
No abstract availableKeywords
Funding Information
- University of Miami
- National Instruments Corporation
- National Science Foundation (1809060, 2041413)
- Foundation for the National Institutes of Health (AG069039)
This publication has 64 references indexed in Scilit:
- Self-propagation of pathogenic protein aggregates in neurodegenerative diseasesNature, 2013
- Lysine-Specific Molecular Tweezers Are Broad-Spectrum Inhibitors of Assembly and Toxicity of Amyloid ProteinsJournal of the American Chemical Society, 2011
- Modeling Neurodegeneration in ZebrafishCurrent Neurology and Neuroscience Reports, 2011
- Molecular Clip and Tweezer Introduce New Mechanisms of Enzyme InhibitionJournal of the American Chemical Society, 2008
- Rhodanine‐Based Tau Aggregation Inhibitors in Cell Models of TauopathyAngewandte Chemie, 2007
- Twenty Years of the Alzheimer’s Disease Amyloid Hypothesis: A Genetic PerspectiveCell, 2005
- Memantine hydrochlorideNature Reviews Drug Discovery, 2004
- The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to TherapeuticsScience, 2002
- Evidence for a Partially Folded Intermediate in α-Synuclein Fibril FormationJournal of Biological Chemistry, 2001
- Alzheimer's Disease: The Amyloid Cascade HypothesisScience, 1992